Affimed N.V. (AFMDQ) vs Decoy Therapeutics Inc (DCOY)
- Affimed N.V. AFMDQ 0.00 NaN
- Decoy Therapeutics Inc DCOY 1.17 −4.88%
Affimed N.V. and Decoy Therapeutics Inc are both Biotechnology companies. Affimed N.V. and Decoy Therapeutics Inc are of similar size ($2.9M and $2.8M). Affimed N.V. has negative trailing earnings, so its P/E is not meaningful; Decoy Therapeutics Inc trades at 0.0×. Decoy Therapeutics Inc grew revenue faster over the last twelve months: −60.5% against −95.2%. Decoy Therapeutics Inc has the higher net margin (−698.8% vs −7,834.6%) and the higher return on invested capital (0.00% vs −13,558.8%). Across the 17 metrics below, Affimed N.V. leads on 9 and Decoy Therapeutics Inc on 8.
Valuation
Profitability
| Metric | AFMDQ | DCOY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 10.57% | 65.16% |
| Operating margin | (7,858.63%) | (706.88%) | 0.00% |
| Net margin | (7,834.59%) | (698.79%) | 0.00% |
| Free cash flow margin | (8,603.91%) | (432.43%) | 0.00% |
| Return on equity | (148.64%) | (827.77%) | (56.36%) |
| Return on assets | (86.68%) | (278.04%) | (48.04%) |
| Return on invested capital | (13,558.83%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack